Physician profile
Julia A Gilbert
NPI 1306171624
$6,498.92
in general payments reported to CMS, 2019-2025
30 companies · $604 in 2025
The $604 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,448 · 2022: $1,186 · 2023: $1,609 · 2024: $1,651 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,784 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,784.16 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $957.02 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $856.11 | 2021-2025 | Mounjaro, Trulicity, Zepbound |
| Abbvie INC. | $851.62 | 2021-2025 | |
| Pfizer INC. | $581.25 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $473.07 | 2022-2025 | Airsupra, Breztri, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $347.51 | 2021-2025 | Jardiance, Stiolto Respimat |
| Amgen INC. | $345.56 | 2021-2025 | Repatha, Otezla, Repatha |
| Janssen Pharmaceuticals, INC | $329.88 | 2021-2022 | |
| Astellas Pharma US INC | $253.54 | 2021-2024 | Veozah, Myrbetriq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.44 | 2021-2025 | Xifaxan, Trulance |
| Abbott Laboratories | $151.77 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $138.73 | 2021-2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $132.01 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $131.09 | 2021-2023 | Steglatro, Belsomra |
| Dexcom, INC. | $128.74 | 2021-2024 | Dexcom G6 Transmitter |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $116.86 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $91.83 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $86.40 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $46.66 | 2024-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $45.05 | 2022-2024 | Trintellix |
| Axsome Therapeutics, INC. | $39.43 | 2025 | Auvelity |
| Kyowa Kirin, INC. | $30.93 | 2024-2025 | Crysvita |
| Novartis Pharmaceuticals Corporation | $28.40 | 2022 | |
| Amarin Pharma, INC. | $24.08 | 2021 | |
| Abiomed | $22.74 | 2024 | Impella |
| Edwards Lifesciences Corporation | $19.19 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Xeris Pharmaceuticals, INC. | $18.97 | 2022 | |
| Spr Therapeutics, INC | $18.85 | 2025 | Sprint Pns System |
| Collegium Pharmaceutical, INC. | $18.44 | 2025 | Jornay Pm |
| Evoke Pharma, INC. | $14.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.